Abstract
Temporal lobe epilepsy (TLE) is the most prevalent subtype of epilepsy in humans and can easily develop into refractory epilepsy. The development of TLE is a complex process involving acute insults, a latent period, and chronic recurrent seizures. The latent period could provide an opportunity for intervention if molecular targets were to be identified. Collapsin response mediator protein 2 (CRMP2) was recently found to be involved in the mechanism of epileptogenesis. However, the results were inconsistent. We aimed to determine if CRMP2 is differentially expressed in rats following status epilepticus (SE), and to validate the expression of CRMP2 during the latent period. We used kainic acid (KA) as the initial insult to induce SE in rats and applied two-dimensional gel electrophoresis (2D-DIGE) coupled with mass spectrometry (MALDI-TOF/TOF) to search for aberrant protein expression in the hippocampus. Western blots were used to confirm the expression level of proteins. Protein extracts of the hippocampus from the sham and the KA groups were separated by 2D-DIGE; 17 protein spots on the gel, representing 10 unique proteins, were found to be significantly different between the KA and sham groups. Among those, CRMP2 was significantly up-regulated. Results of western blot analysis confirmed the increased CRMP2 levels in the KA group. Our findings indicate that the increase in CRMP2 during the latent period is possibly involved in the mechanism of epileptogenesis and is expected to be a novel therapeutic target.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Javidan, M., Epilepsy Res. Treat., 2012, vol. 2012, pp. 637430.
Graebenitz, S., Kedo, O., Speckmann, E.J., Gorji, A., Panneck, H., Hans, V., Palomero-Gallagher, N., Schleicher, A., Zilles, K., and Pape, H.C., Brain, 2011, vol. 134, pp. 2929–2947.
Strzelczyk, A., Griebel, C., Lux, W., Rosenow, F., and Reese, J.P., Front Neurol., 2017, vol. 8, pp. 712.
Yu, Y.H., Lee, K., Sin, D.S., Park, K.H., Park, D.K., and Kim, D.S., Brain Res. Bull., 2017, vol. 131, pp. 25–38.
Gorter, J.A., van Vliet, E.A., and Aronica, E., Epilepsy Behav., 2015, vol. 49, pp. 13–16.
Stone, T.J., Rowell, R., Jayasekera, B.A.P., Cunningham, M.O., and Jacques, T.S., Neuropathol. Appl. Neurobiol., 2018, vol. 44, pp. 56–69.
Durand, E., Watier, L., Fix, M., Weiss, J.J., Chevignard, M., and Pradat-Diehl, P., Brain Inj., 2016, vol. 30, pp. 363–372.
Goshima, Y., Nakamura, F., Strittmatter, P., and Strittmatter, S.M., Nature, 1995, vol. 376, pp. 509–514.
Khanna, R., Wilson, S.M., Brittain, J.M., Weimer, J., Sultana, R., Butterfield, A., and Hensley, K., Future Neurol., 2012, vol. 7, pp. 749–771.
Czech, T., Yang, J.W., Csaszar, E., Kappler, J., Baumgartner, C., and Lubec, G., Neurochem. Res., 2004, vol. 29, pp. 2189–2196.
Lee, C.Y., Jaw, T., Tseng, H.C., Chen, I.C., and Liou, H.H., PLoS One, 2012, vol. 7, p. e38789.
Racine, R.J., Electroencephalogr. Clin. Neurophysiol, 1972, vol. 32, pp. 281–294.
Lubin, F.D., Johnston, L.D., Sweatt, J.D., and Anderson, A.E., Neuroscience, 2005, vol. 133, pp. 969–981.
Wong, M., Epilepsy Curr., 2009, vol. 9, pp. 144–145.
Morinaka, A., Yamada, M., Itofusa, R., Funato, Y., Yoshimura, Y., Nakamura, F., Yoshimura, T., Kaibuchi, K., Goshima, Y., Hoshino, M., Kamiguchi, H., and Miki, H., Sci. Signal, 2011, vol. 4, p. ra26.
Inagaki, N., Chihara, K., Arimura, N., Menager, C., Kawano, Y., Matsuo, N., Nishimura, T., Amano, M., and Kaibuchi, K., Nat. Neurosci., 2001, vol. 4, pp. 781–782.
Greene, N.D., Bamidele, A., Choy, M., de Castro, S.C., Wait, R., Leung, K.Y., Begum, S., Gadian, D.G., Scott, R.C., and Lythgoe, M.F., Proteomics, 2007, vol. 7, pp. 1336–1344.
Wilson, S.M., Xiong, W., Wang, Y., Ping, X., Head, J.D., Brittain, J.M., Gagare, P.D., Ramachandran, P.V., Jin, X., and Khanna, R., Neuroscience, 2012, vol. 210, pp. 451–466.
Zhang, Z., Ottens, A.K., Sadasivan, S., Kobeissy, F.H., Fang, T., Hayes, R.L., and Wang, K.K., J. Neurotrauma, 2007, vol. 24, pp. 460–472.
Arimura, N., Menager, C., Kawano, Y., Yoshimura, T., Kawabata, S., Hattori, A., Fukata, Y., Amano, M., Goshima, Y., Inagaki, M., Morone, N., Usukura, J., and Kaibuchi, K., Mol. Cell Biol., 2005, vol. 25, pp. 9973–9984.
Brown, M., Jacobs, T., Eickholt, B., Ferrari, G., Teo, M., Monfries, C., Qi, R.Z., Leung, T., Lim, L., and Hall, C., J. Neurosci., 2004, vol. 24, pp. 8994–9004.
Uchida, Y., Ohshima, T., Yamashita, N., Ogawara, M., Sasaki, Y., Nakamura, F., and Goshima, Y., J. Biol. Chem., 2009, vol. 284, pp. 27393–27401.
Hou, S.T., Jiang, S.X., Aylsworth, A., Ferguson, G., Slinn, J., Hu, H., Leung, T., Kappler, J., and Kaibuchi, K., J. Neurochem., 2009, vol. 111, pp. 870–881.
Astle, M.V., Ooms, L.M., Cole, A.R., Binge, L.C., Dyson, J.M., Layton, M.J., Petratos, S., Sutherland, C., and Mitchell, C.A., J. Biol. Chem., 2011, vol. 286, pp. 23407–23418.
Zhu, L.Q., Zheng, H.Y., Peng, C.X., Liu, D., Li, H.L., Wang, Q., and Wang, J.Z., J. Neurosci., 2010, vol. 30, pp. 3839–3848.
Wilson, S.M., Ki Yeon, S., Yang, X.F., Park, K.D., and Khanna, R., Front. Cell Neurosci., 2014, vol. 8, pp. 135.
Acknowledgments
We would like to thank Editage for English language editing.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wang, X., Zhang, W., Li, J. et al. Collapsin Response Mediator Protein 2, a Potential Therapeutic Target in Temporal Lobe Epilepsy. Neurochem. J. 13, 188–194 (2019). https://doi.org/10.1134/S1819712419020144
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712419020144